This renewal application seeks support for the training of predoctoral students and postdoctoral fellows in biochemical, chemical, and structural approaches for cancer research. The training program integrates contemporary cancer biology (e.g., oncogenes and tumor suppressors, signal transduction, oncogenic transcription factors, DNA modifications, cell cycle control, genomic surveillance) with the allied fields of chemical and structural biology (high resolution analysis of proteins and DNA, carcinogenic DNA adducts, and chemotherapeutic drug design). Over the past 25 years, this Training Program has an outstanding training record and seeks to continue this multidisciplinary training program that is composed of 26 preceptors from nine academic departments and 2 programs representing both the Vanderbilt University School of Medicine and the College of Arts and Sciences. The training program is conducted within a vibrant academic environment and is supported by close interactions with the Vanderbilt-Ingram NCI-designated Comprehensive Cancer Center, the Vanderbilt Institute of Chemical Biology, and the Vanderbilt Center for Structural Biology, all of which offer resources for trainees and preceptors. In addition to departmental and preceptor-specific laboratory instruction, each trainee receives cancer-related training in the form of two courses focused on cancer biology and experimental cancer research. An Interdisciplinary Graduate Program, the Chemical and Physical Biology Program, and an independent graduate program in Chemistry all academically support predoctoral trainees. This renewal application highlights 8 new enhancements to our training program. An active mentoring program that includes former student trainees, postdoctoral mentors, and faculty mentors ensures the continued development of academic skills for cancer research and career development. Significant institutional investment in training programs, core facilities, state-of-the-art laboratories and equipment that provide technology resources applicable to cancer biology and molecular structures also enhance trainee development. Integrated training in biochemistry, chemistry, structural biology, and cancer biology is critical to the molecular understanding of cancer and the development of new approaches to molecularly targeted therapeutics.
This renewal application seeks support for the training of predoctoral students and postdoctoral fellows in biochemical, chemical, and structural approaches for cancer research. Integrated training in biochemistry, chemistry, structural biology, and cancer biology is critical to the molecular understanding of cancer and the development of new approaches to molecularly targeted therapeutics.
|Carrillo, A M; Bouska, A; Arrate, M P et al. (2015) Mdmx promotes genomic instability independent of p53 and Mdm2. Oncogene 34:846-56|
|Burns, Laura T; Wente, Susan R (2014) From hypothesis to mechanism: uncovering nuclear pore complex links to gene expression. Mol Cell Biol 34:2114-20|
|Lindsey Jr, R Hunter; Pendleton, MaryJean; Ashley, Rachel E et al. (2014) Catalytic core of human topoisomerase II?: insights into enzyme-DNA interactions and drug mechanism. Biochemistry 53:6595-602|
|Pendleton, Maryjean; Lindsey Jr, R Hunter; Felix, Carolyn A et al. (2014) Topoisomerase II and leukemia. Ann N Y Acad Sci 1310:98-110|
|Li, Cunxi; Ma, Haiting; Wang, Yang et al. (2014) Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J Clin Invest 124:2172-87|
|Burns, Michael C; Sun, Qi; Daniels, R Nathan et al. (2014) Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange. Proc Natl Acad Sci U S A 111:3401-6|
|Couch, Frank B; Cortez, David (2014) Fork reversal, too much of a good thing. Cell Cycle 13:1049-50|
|Burns, Laura T; Wente, Susan R (2014) Casein kinase II regulation of the Hot1 transcription factor promotes stochastic gene expression. J Biol Chem 289:17668-79|
|Aldred, Katie J; Kerns, Robert J; Osheroff, Neil (2014) Mechanism of quinolone action and resistance. Biochemistry 53:1565-74|
|Aldred, Katie J; Breland, Erin J; McPherson, Sylvia A et al. (2014) Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge. Antimicrob Agents Chemother 58:7182-7|
Showing the most recent 10 out of 141 publications